Omar Viswanath1,2,3, Ivan Urits4, Emily Bouley4, Jacquelin M Peck5, William Thompson6, Alan David Kaye7. 1. Valley Anesthesiology and Pain Consultants, Envision Physician Services, 645 E. Missouri Avenue, Suite 300, Phoenix, AZ, 85012, USA. viswanoy@gmail.com. 2. Department of Anesthesiology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA. viswanoy@gmail.com. 3. Department of Anesthesiology, Creighton University School of Medicine, Omaha, NE, USA. viswanoy@gmail.com. 4. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. 5. Department of Anesthesiology, Mt. Sinai Medical Center of Florida, Miami Beach, FL, USA. 6. Valley Anesthesiology and Pain Consultants, Phoenix, AZ, USA. 7. Department of Anesthesiology, Louisiana State University Health Science Center, New Orleans, LA, USA.
Abstract
PURPOSE OF REVIEW: Spinal cord stimulation (SCS), based on the gate theory of nociception, has been shown to be effective in the management of chronic pain conditions. While early-generation technology offered many patients improvement in their pain and symptoms, limitations including paresthesia, dependence on mapping, decreased chronological efficacy, and inadequate coverage left many patients with persistent pain and overt therapeutic failure. RECENT FINDINGS: New advances in neuromodulation technology circumvent many of these previous limitations and offer patients improved pain relief and quality of life. In this review, an update on recent technological developments in the field of SCS and peripheral neuromodulation is presented with discussion on differentiating characteristics which may help guide applicability to individual patient needs.
PURPOSE OF REVIEW: Spinal cord stimulation (SCS), based on the gate theory of nociception, has been shown to be effective in the management of chronic pain conditions. While early-generation technology offered many patients improvement in their pain and symptoms, limitations including paresthesia, dependence on mapping, decreased chronological efficacy, and inadequate coverage left many patients with persistent pain and overt therapeutic failure. RECENT FINDINGS: New advances in neuromodulation technology circumvent many of these previous limitations and offer patients improved pain relief and quality of life. In this review, an update on recent technological developments in the field of SCS and peripheral neuromodulation is presented with discussion on differentiating characteristics which may help guide applicability to individual patient needs.
Authors: Antonietta Canna; Lauri J Lehto; Lin Wu; Sheng Sang; Hanne Laakso; Jun Ma; Pavel Filip; Yuan Zhang; Olli Gröhn; Fabrizio Esposito; Clark C Chen; Igor Lavrov; Shalom Michaeli; Silvia Mangia Journal: Sci Rep Date: 2021-03-09 Impact factor: 4.379
Authors: Jan Willem Kallewaard; Jose Francisco Paz-Solis; Pasquale De Negri; Maria Angeles Canós-Verdecho; Hayat Belaid; Simon J Thomson; David Abejón; Jan Vesper; Vivek Mehta; Philippe Rigoard; Paolo Maino; Sarah Love-Jones; Isaac F Peña; Simon Bayerl; Christophe Perruchoud; Renaud Bougeard; Cleo Mertz; Yu Pei; Roshini Jain Journal: J Clin Med Date: 2021-09-10 Impact factor: 4.964